Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 221,816 | -91,426 | -274,880 | -344,681 | -309,242 |
| Depreciation Amortization | 2,568 | 40,819 | 35,453 | 26,680 | 20,122 |
| Accounts receivable | 1,479 | -3,417 | -1,791 | -12,350 | -9,193 |
| Other Working Capital | 21,917 | -19,689 | -14,770 | 19,331 | -2,847 |
| Other Operating Activity | -274,560 | 32,647 | 84,124 | 74,407 | 60,446 |
| Operating Cash Flow | $-26,780 | $-41,066 | $-171,864 | $-236,613 | $-240,714 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -568 | -397 | -3,891 | -1,136 | -167 |
| Purchase Of Investment | -552,737 | -349,457 | -330,713 | -603,014 | -436,071 |
| Sale Of Investment | 451,921 | 420,580 | 497,421 | 415,162 | 388,168 |
| Other Investing Activity | 363,233 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $261,849 | $70,726 | $162,817 | $-188,988 | $-48,070 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 116,734 | N/A | 223,424 | N/A |
| Debt Repayment | -268,408 | 57 | N/A | N/A | N/A |
| Common Stock Issued | 1,684 | -38,111 | 1,301 | 236,253 | 265,725 |
| Common Stock Repurchased | N/A | -75,825 | N/A | N/A | N/A |
| Other Financing Activity | -592 | -1,737 | -1,994 | -2,158 | -2,180 |
| Financing Cash Flow | $-267,316 | $1,118 | $-693 | $457,519 | $263,545 |
| Exchange Rate Effect | -6,302 | -2,023 | 614 | -386 | -1,526 |
| Beginning Cash Position | 94,409 | 65,654 | 74,780 | 43,248 | 70,013 |
| End Cash Position | 55,860 | 94,409 | 65,654 | 74,780 | 43,248 |
| Net Cash Flow | $-38,549 | $28,755 | $-9,126 | $31,532 | $-26,765 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,780 | -41,066 | -171,864 | -236,613 | -240,714 |
| Capital Expenditure | -568 | -397 | -3,891 | -1,136 | -167 |
| Free Cash Flow | -27,348 | -41,463 | -175,755 | -237,749 | -240,881 |